Age-related activation of MKK/p38/NF-κB signaling pathway in lung: From mouse to human

Experimental Gerontology

Volumn 57, Issue , 2014, Pages 29-40

  Ren, Xiaoxia ^a,b   Du, Huadong ^a   Li, Yan ^a,b   Yao, Xiujuan ^a,b   Huang, Junmin ^a,b   Li, Zongli ^a,b   Wang, Wei ^c   Li, Junfa ^d   Han, Song ^d   Wang, Chen ^a,b   Huang, Kewu ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Respiratory Medicine   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

Cytokines; Inflammaging; Lipopolysaccharide; Lung; P38

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; BETA GALACTOSIDASE; CYTOKINE; GLB1 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE;

ADULT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; JUVENILE ANIMAL; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGICAL STRESS;

ADULT; AGED; AGING; ANIMALS; BETA-GALACTOSIDASE; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MIDDLE AGED; NF-KAPPA B; STRESS, PHYSIOLOGICAL;

EID: 84901065417     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.04.017     Document Type: Article

References (68)

1. Anzai T. Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ. J. 2013, 773:580-587.
2. Aoshiba K., Nagai A. Chronic lung inflammation in aging mice. FEBS Lett. 2007, 581:3512-3516.
3. Boehmer E.D., Goral J., Faunce D.E., Kovacs E.J. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J. Leukoc. Biol. 2004, 75:342-349.
4. Boehmer E.D., Meehan M.J., Cutro B.T., Kovacs E.J. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech. Ageing Dev. 2005, 126:1305-1313.
5. Boyd A.R., Shivshankar P., Jiang S., Berton M.T., Orihuela C.J. Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Exp. Gerontol. 2012, 47:507-518.
6. Buxade M., Parra-Palau J.L., Proud C.G. The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front. Biosci. 2008, 13:5359-5373.
7. Cadalbert L.C., Sloss C.M., Cunningham M.R., Al-Mutairi M., McIntire A., Shipley J., Plevin R. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2. Cell. Signal. 2010, 22:357-365.
8. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
9. Chaves M.M., Costa D.C., de, Oliveira B.F., Rocha M.I., Nogueira-Machado J.A. Role PKA and p38 MAPK on ROS production in neutrophil age-related: lack of IL-10 effect in older subjects. Mech. Ageing Dev. 2009, 130:588-591.
10. Chervinsky P., Goldberg P., Galant S., Wang Y., Arledge T., Welch M.B., Stahl E. Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trial. Chest 1999, 115:642-648.
11. Chung K.F. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 2011, 139:1470-1479.
12. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P., Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8:18-30.
13. Coulthard L.R., White D.E., Jones D.L., McDermott M.F., Burchill S.A. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 2009, 15:369-379.
14. Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010, 429:403-417.
15. Dasgupta J., Kar S., Liu R., Joseph J., Kalyanaraman B., Remington S.J., Chen C., Melendez J.A. Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. J. Cell. Physiol. 2010, 225:52-62.
16. Debacq-Chainiaux F., Erusalimsky J.D., Campisi J., Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-beta-gal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 2009, 4:1798-1806.
17. Deniz Y.M., Gupta N. Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody. Clin. Rev. Allergy Immunol. 2005, 29:31-48.
18. - memory T cells. J. Immunol. 2011, 187:2093-2100.
19. Douziech N., Seres I., Larbi A., Szikszay E., Roy P.M., Arcand M., Dupuis G., Fulop T. Modulation of human lymphocyte proliferative response with aging. Exp. Gerontol. 2002, 37:369-387.
20. Fanelli V., Vlachou A., Ghannadian S., Simonetti U., Slutsky A.S., Zhang H. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J. Thorac. Dis. 2013, 5:326-334.
21. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
22. Freund B., Gravenstein S., Elliott M., Miller I. Zanamivir: a review of clinical safety. Drug Saf. 1999, 21:267-281.
23. Gaffey K., Reynolds S., Plumb J., Kaur M., Singh D. Increased phosphorylated p38 mitogen activated protein kinase in COPD lungs. Eur. Respir. J. 2013, 42:28-41.
24. Geller A.M., Zenick H. Aging and the environment: a research framework. Environ. Health Perspect. 2005, 113:1257-1262.
25. Gomez C.R., Goral J., Ramirez L., Kopf M., Kovacs E.J. Aberrant acute-phase response in aged interleukin-6 knockout mice. Shock 2006, 25:581-585.
26. Gomez C.R., Hirano S., Cutro B.T., Birjandi S., Baila H., Nomellini V., Kovacs E.J. Advanced age exacerbates the pulmonary inflammatory response after lipopolysaccharide exposure. Crit. Care Med. 2007, 35:246-251.
27. Gong X., Luo T., Deng P., Liu Z., Xiu J., Shi H., Jiang Y. Stress-induced interaction between p38 MAPK and HSP70. Biochem. Biophys. Res. Commun. 2012, 425:357-362.
28. Gould N.S., Min E., Gauthier S., Chu H.W., Martin R., Day B.J. Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung. Am. J. Respir. Crit. Care Med. 2010, 182:1114-1122.
29. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265:808-811.
30. Hiroshima Y., Hsu K., Tedla N., Chung Y.M., Chow S., Herbert C., Geczy C.L. S100A8 induces IL-10 and protects against acute lung injury. J. Immunol. 2014, 192:2800-2811.
31. Hsieh C.C., Papaconstantinou J. The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid. Mech. Ageing Dev. 2002, 123:1423-1435.
32. Hsieh C.C., Rosenblatt J.I., Papaconstantinou J. Age-associated changes in SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. Mech. Ageing Dev. 2003, 124:733-746.
33. Hsieh C.C., Kuro-o M., Rosenblatt K.P., Brobey R., Papaconstantinou J. The ASK1-signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY) 2010, 2:597-611.
34. Ito Y., Betsuyaku T., Nagai K., Nasuhara Y., Nishimura M. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Exp. Gerontol. 2005, 40:315-323.
35. Ito Y., Betsuyaku T., Nasuhara Y., Nishimura M. Lipopolysaccharide-induced neutrophilic inflammation in the lungs differs with age. Exp. Lung Res. 2007, 33:375-384.
36. Kim M.A., Yi J. Psychological distress in adolescent and young adult survivors of childhood cancer in Korea. J. Pediatr. Oncol. Nurs. 2013, 30:99-108.
37. Larbi A., Douziech N., Fortin C., Linteau A., Dupuis G., Fulop T. The role of the MAPK pathway alterations in GM-CSF modulated human neutrophil apoptosis with aging. Immun. Ageing 2005, 2:6.
38. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Keys J.R., Landvatter S.W., Strickler J.E., Mclaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
39. Li Z., Li J., Bu X., Liu X., Tankersley C.G., Wang C., Huang K. Age-induced augmentation of p38 MAPK phosphorylation in mouse lung. Exp. Gerontol. 2011, 46:694-702.
40. Liu S., Feng G., Wang G.L., Liu G.J. p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway. Eur. J. Pharmacol. 2008, 584:159-165.
41. Long C., Gao Y., Gao G., Han S., Zu P., Fang L., Li J. Decreased phosphorylation and protein expression of ERK1/2 in the brain of hypoxic preconditioned mice. Neurosci. Lett. 2006, 397:307-312.
42. Luciano A.P., Benedet J., de,Abreu L.C., Valenti V.E., de, Souza, Almeida F., de, Vasconcelos F.A., Adami F. Median ages at stages of sexual maturity and excess weight in school children. Reprod. Health 2013, 10. (56).
43. Maijó M., Miró L., Polo J., Campbell J., Russell L., Crenshaw J., Weaver E., Moretó M., Pérez-Bosque A. Dietary plasma proteins modulate the adaptive immune response in mice with acute lung inflammation. J. Nutr. 2012, 142:264-270.
44. Mercer P.F., Williams A.E., Scotton C.J., José R.J., Sulikowski M., Moffatt J.D., Murray L.A., Chambers R.C. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation. Am. J. Respir. Cell Mol. Biol. 2014, 50:144-157.
45. Meyer K.C. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin. Respir. Crit. Care Med. 2010, 31:561-574.
46. Nikolaidis N.M., Kulkarni R.M., Gray J.K., Collins M.H., Waltz S.E. Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate. Immun. 2011, 17:499-507.
47. Nomellini V., Gomez C.R., Gamelli R.L., Kovacs E.J. Aging and animal models of systemic insult: trauma, burn, and sepsis. Shock 2009, 31:11-20.
48. Patel B.V., Wilson M.R., Takata M. Resolution of acute lung injury and inflammation: a translational mouse model. Eur. Respir. J. 2012, 39:1162-1170.
49. Pignatti P., Ragnoli B., Radaeli A., Moscato G., Malerba M. Age-related increase of airway neutrophils in older healthy nonsmoking subjects. Rejuvenation Res. 2011, 14:365-370.
50. Plumb J., Smyth L.J., Adams H.R., Vestbo J., Bentley A., Singh S.D. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur. Respir. J. 2009, 34:89-94.
51. Qian F., Wang X., Zhang L., Chen S., Piecychna M., Allore H., Bockenstedt L., Malawista S., Bucala R., Shaw A.C., Fikrig E., Montgomery R.R. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 2012, 11:104-110.
52. Qiu X., Li H., Tang H., Jin Y., Li W., Yu S., Ping F., Sun X., Xia Z. Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol. 2011, 11:2130-2137.
53. Rahman I., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 2006, 28:219-242.
54. Rahman I., Kinnula V.L., Gorbunova V., Yao H. SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev. Med. 2012, 54:S20-S28.
55. Renda T., Baraldo S., Pelaia G., Bazzan E., Turato G., Papi A., Maestrelli P., Maselli R., Vatrella A., Fabbri L.M., Zuin R., Marsico S.A., Saetta M. Increased activation of p38 MAPK in COPD. Eur. Respir. J. 2008, 31:62-69.
56. Robbiano L., Baroni D., Novello L., Brambilla G. Correlation between induction of DNA fragmentation in lung cells from rats and humans and carcinogenic activity. Mutat. Res. 2006, 605:94-102.
57. Ronkina N., Kotlyarov A., Gaestel M. MK2 and MK3 - a pair of isoenzymes?. Front. Biosci. 2008, 13:5511-5521.
58. Ronkina N., Menon M.B., Schwermann J., Tiedje C., Hitti E., Kotlyarov A., Gaestel M. MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem. Pharmacol. 2010, 80:1915-1920.
59. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994, 78:1027-1037.
60. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., Stern E.J., Hudson L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353:1685-1693.
61. Saito H., Sherwood E.R., Varma T.K., Evers B.M. Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech. Ageing Dev. 2003, 124:1047-1058.
62. Sharma G., Hanania N.A., Shim Y.M. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2009, 6:573-580.
63. Straumann A., Conus S., Degen L., Felder S., Kummer M., Engel H., Bussmann C., Beglinger C., Schoepfer A., Simon H.U. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010, 139:1526-1537.
64. Tang Y., Chen Y., Chu Z., Yan B., Xu L. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice. Eur. J. Pharmacol. 2014, 723:494-500.
65. Vandenbergh J.G. Effect of the presence of a male on the sexual maturation of female mice. Endocrinology 1967, 81:345-349.
66. Wong C.H., Mak G.W., Li M.S., Tsui S.K. The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells. Cytokine 2012, 59:286-293.
67. Wu M., Desai D.H., Kakarla S.K., Katta A., Paturi S., Gutta A.K., Rice K.M., Walker E.M., Blough E.R. Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2. Diabetes Metab. Res. Rev. 2009, 25:279-286.
68. Yeung Y.T., Bryce N.S., Adams S., Braidy N., Konayagi M., McDonald K.L., Teo C., Guillemin G.J., Grewal T., Munoz L. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J. Neurooncol. 2012, 109:35-44.